We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ADRENALINE AGUETTANT (Juno Pharmaceuticals Pty Ltd)
Product name
ADRENALINE AGUETTANT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
169 working days (255)
Active ingredients
Adrenaline (epinephrine) as acid tartrate
Registration type
New generic medicine
Indication
ADRENALINE AGUETTANT (solution for injection) is indicated as an adjunct in the management of cardiac arrest.